Acoramidis
CAS 1446711-81-4Small Molecule
Overview
Acoramidis is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3940890).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Acoramidis expires 16 Aug 2039 and exclusivity 22 Nov 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid
- Canonical SMILES
- CC1=C(C(=NN1)C)CCCOC2=C(C=CC(=C2)C(=O)O)F
- InChIKey
- WBFUHHBPNXWNCC-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.